Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0153-2027

PERMA-HAND Silk Black Braided Sterile Nonabsorbable Surgical Suture, 1X18" TF-5, Product Code: N271H Recall

PERMA-HAND Silk Black Braided Sterile Nonabsorbable Surgical Suture, 1X18" TF-5, Product Code: N271H

FDA recall Class II

Ongoing

FDA lists this Class II recall for PERMA-HAND Silk Black Braided Sterile Nonabsorbable Surgical Suture, 1X18" TF-5, Product Code: N271H. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0153-2027
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Sep 8, 2026
FDA report date
Oct 21, 2026
Quantity in commerce
1764
Distribution
See key details
FDA cause
Process control

What is being recalled?

PERMA-HAND Silk Black Braided Sterile Nonabsorbable Surgical Suture, 1X18" TF-5, Product Code: N271H

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

UDI-DI:Box/Unit: 30705031047369/10705031047365. Lot: RLBDPJ. Expiration: SEPTEMBER 30, 2026

View the original FDA recall notice

Why was this product recalled?

Silk sutures, indicated for use in cardiovascular, ophthalmic and neurological procedures, packaged with alcohol-based fluid, not part of product design, that if discovered prior to use may cause surgical delay. If used, fluid could cause reduced suture tensile strength or knot security, tissue irritation/inflammatory tissue response, and treatment failure, including wound dehiscence/bleeding.

What actions did Ethicon, LLC take?

On 9/8/2026, recall notices were mailed to customers who were asked to do the following: 1) Quarantine affected products. Maintain a copy of this notice with the quarantined product and keep a copy for your records. 2) Communicate the issue to relevant operating room or materials management personnel, or anyone else in your facility who needs to be informed. If any product subject to this recall has been forwarded to another facility, contact that facility to arrange return and forward them this recall notice. 3) Complete and return the Business Reply Form via email to [email protected] 4) Return affected product using the shipping label provided. In addition distributors were told the following: Based on your reported sales data, Ethicon will send notices directly to customers about the product subject to this recall. This notice will include instructions on returning the product for credit reimbursement. Distribute this notice within your organization and to any non-customer organization that received affected product from your facility. If you have additional questions regarding this communication or want to report any product complaints, please contact the firm's Resource Department at 1-877-384-4266.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology